Karyopharm Therapeutics
KPTI
#9732
Rank
HK$0.26 B
Marketcap
HK$31.39
Share price
0.00%
Change (1 day)
197.05%
Change (1 year)

Earnings for Karyopharm Therapeutics (KPTI)

Earnings in 2024 (TTM): -HK$0.31 Billion

According to Karyopharm Therapeutics 's latest financial reports the company's current earnings are HK$0.14 Billion. , an increase over its 2023 earnings that were of -HK$0.93 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Karyopharm Therapeutics from 2013 to 2024

Annual earnings

Year Earnings Change
2024 -HK$0.31 Billion-67.26%
2023 -HK$0.93 Billion-14.99%
2022 -HK$1.09 Billion43.11%
2021 -HK$0.76 Billion-42.09%
2020 -HK$1.32 Billion-8.07%
2019 -HK$1.43 Billion5.76%
2018 -HK$1.35 Billion33.02%
2017 -HK$1.02 Billion19.28%
2016 -HK$0.86 Billion-7.4%
2015 -HK$0.92 Billion55.96%
2014 -HK$0.59 Billion123.21%
2013 -HK$0.27 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
HK$164.79 B-54,556.51%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$65.12 Billion 21,416.06%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$54.49 B-18,108.37%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$5.29 B-1,850.35%๐Ÿ‡บ๐Ÿ‡ธ USA